伍姝
发布单位:衰老与再生医学研究院 发布时间:2021-12-21
伍姝,生物学博士,副研究员,硕士研究生导师。2015年毕业于清华大学获博士学位。研究方向聚焦在核酸结构与修饰在细胞衰老中的作用研究。近五年主要研究成果以第一作者或共同第一作者发表在本领域TOP期刊Nucleic Acids Research,Protein & Cell,PLoS Genetics等杂志。
联系方式:chtyws @ 163. com
学习/工作经历:
2021-12~ 至今 暨南大学,衰老与再生医学研究院,副研究员。
2017-12~2021-12 中山大学,生命科学学院,特聘副研究员。
2015-9~2017-11 中山大学,生命科学学院,博士后。
2008-9~2015-7 清华大学,生命科学学院,博士。
2004-9~2008-7 中央民族大学,生命与环境科学学院,学士。
主要研究方向:
1、端粒染色质结构调控在细胞衰老中的作用研究。
2、RNA结构与修饰在细胞衰老中的作用研究。
承担的主要科研项目:
1、国家自然科学基金面上项目,82271590,2023/01-2026/12,主持。
2、国家自然科学基金青年科学基金,31701196,2018/01-2020/12,主持。
3、广东省基础与应用基础研究基金自然科学基金,2020A15150115522,2019/10-2022/09,主持。
4、高校基本科研业务费青年教师培育项目,18lgpy52,2018/01-2020/12,主持。
5、中国博士后科学基金面上资助(一等),2016M600696,2016/09-2017/09,主持。
发明专利:
赵勇,葛远龙,伍姝。P53转录抑制剂PFTαHBr在制备抗端粒酶阴性p53阳性肿瘤药物中的应用。授权公布号:CN 109045028 B。
主讲课程:
研究生课程《衰老生物学》
代表性研究成果:
1、Shu Wu#, Yuanlong Ge#*, Kaixuan Lin, Qianqian Liu, Haoxian Zhou, Qian Hu, Yong Zhao, Weifeng He*, Zhenyu Ju* (2022). Telomerase RNA TERC and the PI3K-AKT pathway form a positive feedback loop to regulate cell proliferation independent of telomerase activity. Nucleic Acids Research, 50(7): 3764-3776. (TOP, IF2021=19.16)
2、Shu Wu#, Yuanlong Ge#, Xiaocui Li, Yiding Yang, Haoxian Zhou, Kaixuan Lin, Zepeng Zhang, Yong Zhao* (2020). BRM-SWI/SNF chromatin remodeling complex enables functional telomeres by promoting co-expression of TRF2 and TRF1. PLoS Genetics, 16(6): e1008799. (TOP, IF2020=5.917)
3、Yuanlong Ge#, Shu Wu#, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao* (2019). Inhibition of p53 and/or AKT as a New Therapeutic Approach Specifically Targeting ALT Cancers. Protein Cell, 10(11): 808-824. (TOP, IF2019=10.16, 封面文章)
4、Yuanlong Ge#, Shu Wu#, Yong Xue, Jun Tao, Feng Li, Yanlian Chen, Haiying Liu, Wenbin Ma, Junjiu Huang, Yong Zhao* (2016). Preferential extension of short telomeres induced by low extracellular pH. Nucleic Acids Research, 44(17), 8086-8096. (TOP, IF2016=10.162)
5、Shu Wu#, Yuanlong Ge#, Laiqiang Huang, Haiying Liu, Yong Xue, Yong Zhao* (2014). BRG1, the ATPase Subunit of SWI/SNF Chromatin Remodeling Complex, Interacts with HDAC2 to Modulate Telomerase Expression in Human Cancer Cells. Cell Cycle, 13(18): 2869-2878. (IF2014=4.565)
6、Xiaocui Li, Xiaojuan Li, Chen Xie, Sihui Cai, Mengqiu Li, Heping Jin, Shu Wu, Jun Cui, Haiying Liu*, Yong Zhao (2022). cGAS guards against chromosome end-to-end fusions during mitosis and facilitates replicative senescence. Protein Cell, 13(1): 47-64.
7、Juanhong Liu#, Yuanlong Ge#, Shu Wu, Delin Ma, Weijie Xu, Ye Zhang, and Yan Yang* (2019). Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. Aging-US, 11(2): 741-755.
8、Yi Zheng#, Yicheng Yang#, Shu Wu, Yongqiang Zhu, Xiaolong Tang, Xiaopeng Liu (2017). Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer. Bioengineered, 8(4): 367-373.
9、Yongqiang Zhu, Yi Zheng, Lin Mei, Mengqiong Liu, Shanshan Li, Huawei Xiao, Huijun Zhu, Shu Wu, Hongbo Chen, Laiqiang Huang* (2013). Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus. Int J Oncol, 43(4): 1151-1159.
10、Bo Qiu#, Minghui Ji#, Xiaosong Song, Yongqiang Zhu, Zhongyuan Wang, Xudong Zhang, Shu Wu, Hongbo Chen, Lin Mei*, Yi Zheng* (2012). Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer. Nanoscale Research Letters, 7(1):666.